Related references
Note: Only part of the references are listed.NPTX2 and cognitive dysfunction in Alzheimers Disease
Mei-Fang Xiao et al.
ELIFE (2017)
Signaling pathway cross talk in Alzheimer's disease
Juan A. Godoy et al.
CELL COMMUNICATION AND SIGNALING (2014)
Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study
Masaaki Hokama et al.
CEREBRAL CORTEX (2014)
Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches
J. A. Mikulca et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
REST and stress resistance in ageing and Alzheimer's disease
Tao Lu et al.
NATURE (2014)
Wnt signaling in the nervous system and in Alzheimers disease
Nibaldo C. Inestrosa et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage
P. Hemachandra Reddy
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease
Marcus O. W. Grimm et al.
BIOMED RESEARCH INTERNATIONAL (2013)
AMP Is an Adenosine A1 Receptor Agonist
Joseph E. Rittiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Roles of AMP-activated Protein Kinase in Alzheimer's Disease
Zhiyou Cai et al.
NEUROMOLECULAR MEDICINE (2012)
Alzheimer's Association Report 2011 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2011)
AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure
Claire Thornton et al.
BIOCHEMICAL JOURNAL (2011)
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Catarina V. Gomes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Zsolt Kovacs et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease
Eric M. Blalock et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways
Kyoung Ja Kwon et al.
JOURNAL OF CLINICAL NEUROLOGY (2010)
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease
Maria Cristina Rosi et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
Julian Heuberger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The Role of Adenosine in Alzheimer's Disease
Anisur Rahman
CURRENT NEUROPHARMACOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential β-catenin phosphorylation
Monica D. David et al.
JOURNAL OF CELL SCIENCE (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
DrugBank: a knowledgebase for drugs, drug actions and drug targets
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2008)
Crystal structure of human guanosine monophosphate reductase 2 (GMPR2) in complex with GMP
JX Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease
LJ Cook et al.
NEUROSCIENCE LETTERS (2004)
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
EM Blalock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)